Log in to save to my catalogue

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomog...

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomog...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_008ae21676f04681a593326335e109f8

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease

About this item

Full title

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease

Publisher

England: BioMed Central Ltd

Journal title

Alzheimer's research & therapy, 2021-02, Vol.13 (1), p.46-46, Article 46

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Recognizing clinical manifestations heralding the development of Alzheimer's disease (AD)-related cognitive impairment could improve the identification of individuals at higher risk of AD who may benefit from potential prevention strategies targeting preclinical population. We aim to characterize the association of body weight change with cognitive...

Alternative Titles

Full title

Association of weight change with cerebrospinal fluid biomarkers and amyloid positron emission tomography in preclinical Alzheimer's disease

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_008ae21676f04681a593326335e109f8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_008ae21676f04681a593326335e109f8

Other Identifiers

ISSN

1758-9193

E-ISSN

1758-9193

DOI

10.1186/s13195-021-00781-z

How to access this item